Abstract
Immediate postmastectomy reconstruction has become an increasingly popular choice for breast cancer patients recently. However, whether molecular subtype of cancer impacts the incidence of breast reconstruction is unclear. We aimed to investigate the association between breast cancer subtype defined by immunohistochemistry hormone receptor (HR) and human epidermal growth factor receptor 2 (HER2) status and recent rates of immediate postmastectomy reconstruction in the United States.The National Cancer Institute's Surveillance, Epidemiology, and End Results (SEER) database was used to evaluate stage I-III breast cancer patients with different subtypes who underwent either mastectomy alone or mastectomy plus reconstruction between 2010 and 2012. Univariate and multivariate analyses were conducted to identify factors influencing the incidence of immediate reconstruction.Of 47,123 women included, 33.1% (10,712/32,376) of HR+/HER2-, 33.1% (1912/5768) of HR+/HER2+, 29.6% (850/2875) of HR-/HER2+, and 27.7% (1689/6104) of triple negative breast cancer patients received immediate breast reconstruction (chi-square test, P < 0.001), respectively. Thus, HER2-overexpressing and triple negative breast cancer patients received significantly l...Continue Reading
References
Feb 26, 1983·Lancet·C DeanA P Forrest
Sep 7, 2000·Journal of the National Cancer Institute·J H RowlandP A Ganz
Feb 1, 2003·Plastic and Reconstructive Surgery·Amy K AldermanEdwin G Wilkins
Mar 4, 2005·Breast Cancer Research : BCR·Gem M LeDee W West
Aug 24, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Roman RouzierLajos Pusztai
Jan 25, 2006·Annals of Surgery·Caprice K ChristianJane C Weeks
Jun 8, 2006·JAMA : the Journal of the American Medical Association·Lisa A CareyRobert C Millikan
Apr 18, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Lisa A CareyCharles M Perou
Jan 23, 2008·Breast Cancer Research and Treatment·J Y PetitA Luini
Feb 7, 2008·Cancer·Hae-Chung YangBarbara L Andersen
Feb 28, 2008·Plastic and Reconstructive Surgery·Colleen M McCarthyPeter G Cordeiro
Apr 9, 2008·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J Fernández-DelgadoM M Reza
Jun 27, 2008·Annals of Plastic Surgery·Lisbet Rosenkrantz HölmichSøren Friis
Mar 25, 2009·American Journal of Surgery·Brian C ReubenLeigh A Neumayer
Jul 28, 2009·Cancer·Michael BezuhlyE Francis Cook
May 26, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Hagen KenneckeKaren Gelmon
Jul 1, 2010·Archives of Pathology & Laboratory Medicine·M Elizabeth H HammondUNKNOWN College of American Pathologists
Sep 3, 2010·Medical Care·Steven J KatzTimothy P Hofer
Dec 15, 2010·Molecular Oncology·Aleix Prat, Charles M Perou
Mar 17, 2011·Breast Cancer Research and Treatment·C EriksenK Sandelin
May 24, 2011·The Breast : Official Journal of the European Society of Mastology·Thomas NedumparaMichael R Williams
May 28, 2011·The Breast Journal·Shailesh AgarwalJayant Agarwal
Dec 8, 2011·Breast Cancer Research and Treatment·Aoife J LoweryKarl J Sweeney
Jan 10, 2012·Journal of the American College of Surgeons·Beth Aviva PremingerChristine Rohde
Dec 25, 2012·Annals of Surgical Oncology·Haejin InCaprice C Greenberg
Jan 15, 2013·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·M C KneubilM Rietjens
Aug 22, 2014·JAMA Surgery·Monica MorrowSteven J Katz
Jan 30, 2015·Plastic and Reconstructive Surgery·Mazen E IskandarMark L Smith
Feb 14, 2015·The Journal of Surgical Research·Anaeze C OffodileLifei Guo